Skip to content

Arena Pharmaceuticals, Inc.: filings

Every Arena Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 43 filings, each linked to its SEC index.

Filing record ends 2022-02-23

The latest filing in this captured record is a 10-K filed 2022-02-23. No later filing is in the SEC companyfacts record captured on 2026-09-22. Arena Pharmaceuticals, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2022-02-23fiscal FY 2021421090001080709-22-000006
10-Q2021-11-04fiscal Q3 2021391120001080709-21-000038
10-Q2021-08-05fiscal Q2 2021401120001080709-21-000031
10-Q2021-05-05fiscal Q1 202140820001628280-21-009104
10-K2021-02-23fiscal FY 2019451460001564590-21-007609
10-Q2020-11-09fiscal Q3 2020411180001564590-20-052539
10-Q2020-08-05fiscal Q2 2020411130001564590-20-036902
10-Q2020-05-07fiscal Q1 202042840001564590-20-022995
10-K2020-02-27fiscal FY 2019461490001564590-20-007399
10-Q2019-11-08fiscal Q3 2019431210001564590-19-042020
10-Q2019-08-09fiscal Q2 2019451190001564590-19-030945
10-Q2019-05-09fiscal Q1 201943850001564590-19-018015
10-K2019-02-28fiscal FY 2018441350001564590-19-005441
10-Q2018-11-08fiscal Q3 201835900001564590-18-028552
10-Q2018-08-07fiscal Q2 201835890001564590-18-019939
10-Q2018-05-09fiscal Q1 201836710001564590-18-012393
10-K2018-03-14fiscal FY 2017401300001564590-18-005660
10-Q2017-11-08fiscal Q3 2017401100001564590-17-022741
10-Q2017-08-08fiscal Q2 2017401100001564590-17-016507
10-Q2017-05-09fiscal Q1 201740820001564590-17-009873
10-K2017-03-15fiscal FY 2016431330001564590-17-004354
10-Q2016-11-09fiscal Q3 2016401100001564590-16-028613
10-Q2016-08-09fiscal Q2 2016381040001564590-16-023370
10-Q2016-05-09fiscal Q1 201640820001628280-16-015959
10-K2016-02-29fiscal FY 2015431320001628280-16-011994
10-Q2015-11-09fiscal Q3 2015401090001628280-15-008555
10-Q2015-08-07fiscal Q2 2015401090001628280-15-006320
10-Q2015-05-11fiscal Q1 201537770001193125-15-182233
10-K2015-03-02fiscal FY 2014411250001193125-15-073420
10-Q2014-11-06fiscal Q3 2014381040001193125-14-401207
10-Q2014-08-06fiscal Q2 2014361000001193125-14-298319
10-Q2014-05-12fiscal Q1 201439800001193125-14-194844
10-K2014-03-03fiscal FY 2013461380001193125-14-080400
10-Q2013-11-12fiscal Q3 2013401100001193125-13-438170
10-Q2013-08-05fiscal Q2 2013401100001193125-13-317504
10-Q2013-05-09fiscal Q1 201340820001193125-13-211400
10-K2013-03-01fiscal FY 2012461380001193125-13-087866
10-Q2012-11-09fiscal Q3 2012401130001193125-12-461303
10-Q2012-08-09fiscal Q2 2012371050001193125-12-347821
10-Q2012-05-02fiscal Q1 201235720001193125-12-201877
10-K2012-03-15fiscal FY 2011381040001193125-12-117359
10-Q2011-11-09fiscal Q3 2011351000001193125-11-304696
10-Q2011-08-09fiscal Q2 2011351000001193125-11-216567

Inspect the source

Entity
Arena Pharmaceuticals, Inc. / CIK 0001080709
Captured
SEC response SHA-256
b90c01c7a69359e48c67ac8bd7a307b3586dbbfa82bf316742f29b8287f24976

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001080709.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))